Synergic effect of polymorphisms in ERCC6 5' flanking region and complement factor H on age-related macular degeneration predisposition.

This study investigates age-related macular degeneration (AMD) genetic risk factors through identification of a functional single-nucleotide polymorphism (SNP) and its disease association. We chose ERCC6 because of its roles in the aging process, DNA repair, and ocular degeneration from the gene disruption. Bioinformatics indicated a putative binding-element alteration on the sequence containing C-6530>G SNP in the 5' flanking region of ERCC6 from Sp1 on the C allele to SP1, GATA-1, and OCT-1 on the G allele. Electrophoretic mobility shift assays displayed distinctive C and G allele-binding patterns to nuclear proteins. Luciferase expression was higher in the vector construct containing the G allele than that containing the C allele. A cohort of 460 advanced AMD cases and 269 age-matched controls was examined along with pathologically diagnosed 57 AMD and 18 age-matched non-AMD archived cases. ERCC6 C-6530>G was associated with AMD susceptibility, both independently and through interaction with an SNP (rs380390) in the complement factor H (CFH) intron reported to be highly associated with AMD. A disease odds ratio of 23 was conferred by homozygozity for risk alleles at both ERCC6 and CFH compared with homozygozity for nonrisk alleles. Enhanced ERCC6 expression was observed in lymphocytes from healthy donors bearing ERCC6 C-6530>G alleles. Intense immunostaining of ERCC6 was also found in AMD eyes from ERCC6 C-6530>G carriers. The strong AMD predisposition conferred by the ERCC6 and CFH SNPs may result from biological epistasis, because ERCC6 functions in universal transcription as a component of RNA pol I transcription complex.

[1]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[2]  D. Weeks,et al.  Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy. , 2005, Human molecular genetics.

[3]  Boraz Ra Cockayne's syndrome: literature review and case report. , 1991 .

[4]  S M Meyers,et al.  A twin study of age-related macular degeneration. , 1995, American journal of ophthalmology.

[5]  J. Tuo,et al.  Genetic factors of age-related macular degeneration , 2004, Progress in Retinal and Eye Research.

[6]  G. Fròsina,et al.  Overexpression of enzymes that repair endogenous damage to DNA. , 2000, European journal of biochemistry.

[7]  P. Jong Prevalence of age-related macular degeneration in the United States. , 2004 .

[8]  L. Hjelmeland,et al.  ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. , 1996, Experimental eye research.

[9]  J D Gottsch,et al.  Oxidative damage and age-related macular degeneration. , 1999, Molecular vision.

[10]  J. Gilbert,et al.  Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.

[11]  Y. Seo,et al.  Imbalancing the DNA base excision repair pathway in the mitochondria; targeting and overexpressing N-methylpurine DNA glycosylase in mitochondria leads to enhanced cell killing. , 2003, Cancer research.

[12]  G. Fròsina Counteracting spontaneous transformation via overexpression of rate-limiting DNA base excision repair enzymes. , 2001, Carcinogenesis.

[13]  A E Fletcher,et al.  28 000 Cases of age related macular degeneration causing visual loss in people aged 75 years and above in the United Kingdom may be attributable to smoking , 2005, British Journal of Ophthalmology.

[14]  M. Kelley,et al.  Transient adenoviral N-methylpurine DNA glycosylase overexpression imparts chemotherapeutic sensitivity to human breast cancer cells. , 2004, Molecular cancer therapeutics.

[15]  L. Hyman,et al.  Risk factors for age-related macular degeneration: an update , 2002, Current opinion in ophthalmology.

[16]  Familial Aggregation of Age-related Maculopathy , 1997 .

[17]  E. Chew,et al.  The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age‐related macular degeneration , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  J. Nickoloff,et al.  Overexpression of human RAD51 and RAD52 reduces double-strand break-induced homologous recombination in mammalian cells. , 2001, Nucleic acids research.

[19]  Jason H. Moore,et al.  A global view of epistasis , 2005, Nature Genetics.

[20]  M. Boulton,et al.  The role of oxidative stress in the pathogenesis of age-related macular degeneration. , 2000, Survey of ophthalmology.

[21]  Jennifer I. Lim,et al.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.

[22]  W. Willett,et al.  Dietary fat and risk for advanced age-related macular degeneration. , 2001, Archives of ophthalmology.

[23]  Robert B Sim,et al.  Interactions between human complement components factor H, factor I and C3b. , 1997, The Biochemical journal.

[24]  W. Green,et al.  Detection of CX3CR1 single nucleotide polymorphism and expression on archived eyes with age-related macular degeneration. , 2005, Histology and histopathology.

[25]  J. Sahel,et al.  Ocular manifestations in the inherited DNA repair disorders. , 2003, Survey of ophthalmology.

[26]  B S Hawkins,et al.  Epidemiology of age-related macular degeneration. , 1999, Molecular vision.

[27]  J. Vonesch,et al.  CSB is a component of RNA pol I transcription. , 2002, Molecular cell.

[28]  B. Godley,et al.  Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration. , 2003, Experimental eye research.

[29]  Johanna M Seddon,et al.  The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. , 2005, Archives of ophthalmology.

[30]  A Hofman,et al.  Genetic risk of age-related maculopathy. Population-based familial aggregation study. , 1998, Archives of ophthalmology.

[31]  L. Gold,et al.  Endogenous mutagens and the causes of aging and cancer. , 1991, Mutation research.

[32]  R. Conaway,et al.  Transcription elongation and human disease. , 1999, Annual review of biochemistry.

[33]  M. Müftüoğlu,et al.  The Cockayne Syndrome Group B Gene Product Is Involved in General Genome Base Excision Repair of 8-Hydroxyguanine in DNA* , 2001, The Journal of Biological Chemistry.

[34]  C. Klaver,et al.  Age-related maculopathy: Its genetic basis , 2001, Eye.

[35]  V. Bohr,et al.  Functional crosstalk between hOgg1 and the helicase domain of Cockayne syndrome group B protein. , 2002, DNA repair.

[36]  D. Friedman,et al.  Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey. , 1999, Ophthalmology.

[37]  Philip C. Hanawalt,et al.  DNA repair: The bases for Cockayne syndrome , 2000, Nature.

[38]  R. T. Smith,et al.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[39]  George A. Williams,et al.  The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1. , 1999, Controlled clinical trials.

[40]  W. Green,et al.  Histopathology of the eye in Cockayne's syndrome. , 1983, Archives of ophthalmology.

[41]  P. Hanawalt,et al.  Effect of DNA lesions on transcription elongation. , 1999, Biochimie.

[42]  T. Matise,et al.  Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q. , 1998, Archives of ophthalmology.

[43]  D. Weeks,et al.  A full genome scan for age-related maculopathy. , 2000, Human molecular genetics.

[44]  Jurg Ott,et al.  Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. , 2005, American journal of human genetics.

[45]  Johanna M Seddon,et al.  Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. , 2003, Ophthalmology.

[46]  E. Traboulsi,et al.  Ocular findings in Cockayne syndrome. , 1992, American journal of ophthalmology.